Raymond James Financial Services Advisors, Inc. Bio N Tech Se Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 3,301 shares of BNTX stock, worth $398,496. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,301

Previous 3,748 11.93%

Holding current value

$398,496

Previous $301,000 30.23%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$78.36 - $124.66 $35,026 - $55,723	-447 Reduced 11.93%	3,301 $392,000
Q2 2024 Jul 19, 2024	SELL	$80.36 - $102.87 $134,361 - $171,998	-1,672 Reduced 30.85%	3,748 $301,000
Q1 2024 Apr 22, 2024	SELL	$88.96 - $112.35 $105,951 - $133,808	-1,191 Reduced 18.02%	5,420 $499,000
Q4 2023 Jan 16, 2024	BUY	$90.91 - $112.75 $128,274 - $159,090	1,411 Added 27.13%	6,611 $697,000
Q3 2023 Oct 24, 2023	SELL	$98.5 - $125.08 $705,260 - $895,572	-7,160 Reduced 57.93%	5,200 $564,000
Q2 2023 Jul 25, 2023	SELL	$102.58 - $129.66 $144,022 - $182,042	-1,404 Reduced 10.2%	12,360 $1.33 Million
Q1 2023 Apr 14, 2023	SELL	$122.57 - $153.67 $143,897 - $180,408	-1,174 Reduced 7.86%	13,764 $1.71 Million
Q4 2022 Feb 08, 2023	BUY	$118.43 - $186.05 $196,593 - $308,843	1,660 Added 12.5%	14,938 $2.24 Million
Q3 2022 Oct 25, 2022	BUY	$127.65 - $183.11 $293,212 - $420,603	2,297 Added 20.92%	13,278 $1.79 Million
Q2 2022 Aug 12, 2022	BUY	$123.25 - $186.24 $762,054 - $1.15 Million	6,183 Added 128.87%	10,981 $1.64 Million
Q1 2022 May 11, 2022	SELL	$126.25 - $231.85 $132,562 - $243,442	-1,050 Reduced 17.95%	4,798 $818,000
Q4 2021 Feb 08, 2022	SELL	$216.64 - $362.52 $706,463 - $1.18 Million	-3,261 Reduced 35.8%	5,848 $1.51 Million
Q3 2021 Nov 02, 2021	BUY	$205.93 - $447.23 $656,504 - $1.43 Million	3,188 Added 53.84%	9,109 $2.49 Million
Q2 2021 Aug 11, 2021	SELL	$113.32 - $241.49 $387,667 - $826,137	-3,421 Reduced 36.62%	5,921 $1.33 Million
Q1 2021 May 14, 2021	SELL	$85.73 - $119.5 $25,719 - $35,850	-300 Reduced 3.11%	9,342 $1.02 Million
Q4 2020 Feb 12, 2021	SELL	$72.71 - $129.54 $160,034 - $285,117	-2,201 Reduced 18.58%	9,642 $786,000
Q3 2020 Nov 04, 2020	BUY	$57.81 - $104.17 $128,685 - $231,882	2,226 Added 23.15%	11,843 $820,000
Q2 2020 Jul 17, 2020	BUY	$38.58 - $66.74 $371,023 - $641,838	9,617 New	9,617 $642,000

Others Institutions Holding BNTX

# of Institutions

357

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $29.3B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account

Raymond James Financial Services Advisors, Inc. Bio N Tech Se Transaction History